The United States Nuclear Regulatory Commission (NRC) released a on a asking the agency to require reporting of certain nuclear medicine injection extravasations as Medical Events (MEs) under . Currently, the NRC encourages — but does not require — use of quality assurance tools and technologies to ensure radioactive materials are administered as intended, and extravasation has generally been viewed by the agency as a practice of medicine issue.
The petitioner — a manufacturer of an infiltration detection/measurement system — specifically requested that extravasations resulting in a localized dose equivalent exceeding 50 rem (0.5 Sv) be subject to ME reporting requirements. Compliance with the petitioner’s requested change would presumably mandate the use of certain technologies during relevant administrations.
The 新澳门六合彩官网® (新澳门六合彩官网®) Commission on Government Relations-Federal Regulatory Committee and Commission on Medical Physics-Government Relations Committee are currently reviewing the issue and compiling input. 新澳门六合彩官网 members with an interest are encouraged to and email feedback to the 新澳门六合彩官网 Director of Legislative and Regulatory Affairs, Michael Peters, at mpeters@acr.org. All member feedback will help inform future comment development efforts of the 新澳门六合彩官网.